tiprankstipranks
Enfusion (ENFN)
NYSE:ENFN
US Market

Enfusion (ENFN) Technical Analysis

Compare
35 Followers

Technical Sentiment

Overall Consensus
Strong Sell
2Bullish
0Neutral
11Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Enfusion’s (ENFN) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting Enfusion is a Buy.
Enfusion’s (ENFN) 20-Day exponential moving average is 11.08, while Enfusion’s (ENFN) share price is $10.59, making it a Sell.
Enfusion’s (ENFN) 50-Day exponential moving average is 11.02, while Enfusion’s (ENFN) share price is $10.59, making it a Sell.

Enfusion (ENFN) Pivot Points

Apr 06, 2025, 02:31 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
10.94
10.98
11.07
11.11
11.20
11.24
11.33
Fibonacci
10.98
11.03
11.06
11.11
11.16
11.19
11.24
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Enfusion (ENFN) Moving Averages

Apr 06, 2025, 02:31 AM
Period
Simple
Exponential
MA5
11.00Sell
10.92Sell
MA10
11.07Sell
11.01Sell
MA20
11.08Sell
11.08Sell
MA50
11.17Sell
11.02Sell
MA100
10.74Sell
10.68Sell
MA200
9.72Buy
10.00Buy
Enfusion’s (ENFN) 10-Day exponential moving average is 11.01, while Enfusion’s (ENFN) share price is $10.59, making it a Sell.
Enfusion’s (ENFN) 100-Day exponential moving average is 10.68, while Enfusion’s (ENFN) share price is $10.59, making it a Sell.
Enfusion’s (ENFN) stock price is $10.59 and Enfusion’s (ENFN) 50-day simple moving average is 11.17, creating a Sell signal.
Enfusion’s (ENFN) stock price is $10.59 and Enfusion’s (ENFN) 100-day simple moving average is 10.74, creating a Sell signal.
Enfusion’s (ENFN) stock price is $10.59 and Enfusion’s (ENFN) 200-day simple moving average is 9.72, creating a Buy signal.

Enfusion (ENFN) Technical Indicators

Apr 06, 2025, 02:31 AM
Name
Value
Implied Action
RSI (14)
47.45
Neutral
STOCH (9,6)
54.03
Neutral
STOCHRSI (14)
55.56
Neutral
MACD (12,26)
-0.01
Buy
ADX (14)
14.87
Buy
Williams %R
-50.00
Buy
CCI (14)
-31.30
Neutral
ATR (14)
0.12
-
Ultimate Oscillator
49.12
Neutral
ROC
-4.34
Sell
Enfusion’s (ENFN) Relative Strength Index (RSI) is 47.45, creating a Neutral signal.
Enfusion’s (ENFN) Trend Strength Indicator (ADX) is 14.87, creating a Buy signal.
Enfusion’s (ENFN) Commodity Channel Index (CCI) is -31.30, creating a Neutral signal.
Enfusion’s (ENFN) Price Rate of Change (ROC) is -4.34, creating a Sell signal.

FAQ

Is ENFN a Buy, Hold, or Sell?
Based on ENFN’s technical indicators, ENFN is a Strong Sell.
    What is ENFN’s RSI (14)?
    ENFN’s RSI (14) is 47.45, which suggests ENFN is a Neutral.
      What is ENFN’s MACD?
      ENFN’s MACD is -0.01, which suggests ENFN is a Buy.
        What is ENFN’s 5-day moving average?
        ENFN’s 5-day moving average is 11.00, which suggests ENFN is a Sell.
          What is ENFN’s 20-day moving average?
          ENFN 20-day moving average is 11.08, which suggests ENFN is a Sell.
            What is ENFN’s 50-day moving average?
            ENFN’s 50-day moving average is 11.17, which suggests ENFN is a Sell.
              What is ENFN’s 200-day moving average?
              ENFN’s 200-day moving average is 9.72, which suggests ENFN is a Buy.
                What is ENFN’s Williams % R (14)?
                ENFN’s Williams % R (14) is -50.00, which suggests ENFN is a Buy.
                  What is ENFN’s CCI (14)?
                  ENFN’s CCI (14) is -31.30, which suggests ENFN is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis